Navigation Links
BGI and TGAC join efforts to tackle global challenges in food security, energy and health
Date:3/12/2013

Norwich, UK, Copenhagen, Denmark, Shenzhen, China. Tue., 12 March 2013 - The Genome Analysis Centre (TGAC) and BGI, the world's largest genomics organization, will be working together aiming to strengthen research collaborations and build on the world-class genomics and bioinformatics capabilities of both institutions. This partnership will foster key research developments in the areas of food security, energy and health.

Prof Richard Cogdell, chair of TGAC's board of trustees, said, "I am delighted by the prospect of a strong synergistic collaboration between TGAC and BGI. This will allow both partners to work together on exciting and high priority projects, bringing them to fruition much faster than if they were working alone"

Crop genomics represents one of the critical areas this joint effort will contribute to. BGI and TGAC are already working on important crop species including wheat, rice and barley. The Norwich Research Park (NRP) where TGAC is based also hosts the John Innes Centre and the Sainsbury Laboratory, two world-renowned research centres in plant genomics and plant pathogen research. Routes to better crops and tackling challenges around food security will be investigated by the application of the latest sequencing technologies coupled with novel computational solutions such as the rapid identification of alleles associated with advantageous traits. Another important theme will be energy derived from crops.

Scientists from both BGI and TGAC will also join efforts to explore the application of genomics for medical diagnostic and its impact on health. This collaboration will also offer opportunities to work with the Institute of Food Research, a research institute with expertise in food-borne pathogens and nutrition, and the University of East Anglia including the medical school in the Norfolk and Norwich University Hospital, all based within the NRP.

"This is a great opportunity to build on our relationship with BGI and form a long term collaboration with them. The Norwich Research Park has emerged as a leader in plant genomics research and biotechnology" said TGAC Acting Director, Dr. Mario Caccamo. "The partnership between TGAC and BGI will facilitate future implementation of novel solutions to tackle important global challenges in food security and sustainable energy".

Ning Li, Director of BGI Europe, said, "This agreement provides a perfect platform for researchers from BGI and TGAC to share and exchange knowledge and research ideas. I am positive about this collaboration. We would like to collaborate with more researchers in Europe to better accelerate the genomic studies on human health, agriculture, bio-energy as well as other innovative research."

The intention of this collaboration includes the creation of a fellowship programme for early-career Chinese researchers to access the expertise and education opportunities in the NRP. Equally partners within the NRP, university faculty and students will gain access to the expertise of the World's largest genomics center.


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
2. Report details efforts to improve, advance indoor microbial sampling
3. Efforts to develop new drugs that hopefully will never be used
4. Computing advances vital to sustainability efforts; new report recommends problem-focused, iterative approach to research
5. Researchers take hibiscus efforts to commercialization
6. Tamarisk biocontrol efforts get evolutionary boost
7. Guam conservation efforts progress
8. Environmental groups should pool efforts to reach the public
9. NSF research alliances begin new efforts to accelerate innovation
10. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
11. State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 27, 2017 Four US Biotech ... today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), ... Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: ... Trends, market observers are growing more bullish on the ... reforms to free cash held overseas for tax reason ...
(Date:2/27/2017)... , ... February 27, 2017 , ... The Catalyst ... a few in the Midwest offering premix services and private label organic services. , ... laying hens, according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the ...
(Date:2/24/2017)... ... ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced ... for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ). The ... therapeutic levels of olanzapine for a period of 3 months., “We are honored and ...
(Date:2/24/2017)... SAN FRANCISCO , Feb. 24, 2017 ... that is developing a new category of therapeutics, announced ... trial of SB-030 in peripheral artery disease. The trial ... locally administered single-use therapeutic, in the reduction of restenosis ... reached this critical development milestone for SB-030," said ...
Breaking Biology Technology: